202 related articles for article (PubMed ID: 27090575)
1. Detailed gene dose analysis reveals recurrent focal gene deletions in pediatric B-cell precursor acute lymphoblastic leukemia.
Ivanov Öfverholm I; Tran AN; Olsson L; Zachariadis V; Heyman M; Rudd E; Syk Lundberg E; Nordenskjöld M; Johansson B; Nordgren A; Barbany G
Leuk Lymphoma; 2016 Sep; 57(9):2161-70. PubMed ID: 27090575
[TBL] [Abstract][Full Text] [Related]
2. CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocol.
Ghazavi F; Clappier E; Lammens T; Suciu S; Caye A; Zegrari S; Bakkus M; Grardel N; Benoit Y; Bertrand Y; Minckes O; Costa V; Ferster A; Mazingue F; Plat G; Plouvier E; Poirée M; Uyttebroeck A; van der Werff-Ten Bosch J; Yakouben K; Helsmoortel H; Meul M; Van Roy N; Philippé J; Speleman F; Cavé H; Van Vlierberghe P; De Moerloose B
Haematologica; 2015 Oct; 100(10):1311-9. PubMed ID: 26137961
[TBL] [Abstract][Full Text] [Related]
3. Frequency of copy number abnormalities in common genes associated with B-cell precursor acute lymphoblastic leukemia cytogenetic subtypes in Brazilian children.
Barbosa TC; Terra-Granado E; Quezado Magalhães IM; Neves GR; Gadelha A; Guedes Filho GE; Souza MS; Melaragno R; Emerenciano M; Pombo-de-Oliveira MS
Cancer Genet; 2015 Oct; 208(10):492-501. PubMed ID: 26277549
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols.
Ribera J; Morgades M; Zamora L; Montesinos P; Gómez-Seguí I; Pratcorona M; Sarrà J; Guàrdia R; Nomdedeu J; Tormo M; Martínez-Lopez J; Hernández-Rivas JM; González-Campos J; Barba P; Escoda L; Genescà E; Solé F; Millá F; Feliu E; Ribera JM;
Cancer; 2015 Nov; 121(21):3809-17. PubMed ID: 26194343
[TBL] [Abstract][Full Text] [Related]
5. The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013.
Olsson L; Ivanov Öfverholm I; Norén-Nyström U; Zachariadis V; Nordlund J; Sjögren H; Golovleva I; Nordgren A; Paulsson K; Heyman M; Barbany G; Johansson B
Br J Haematol; 2015 Sep; 170(6):847-58. PubMed ID: 26018335
[TBL] [Abstract][Full Text] [Related]
6. Gene copy number alteration profile and its clinical correlation in B-cell acute lymphoblastic leukemia.
Gupta SK; Bakhshi S; Kumar L; Kamal VK; Kumar R
Leuk Lymphoma; 2017 Feb; 58(2):333-342. PubMed ID: 27339065
[TBL] [Abstract][Full Text] [Related]
7. Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features.
Schwab CJ; Chilton L; Morrison H; Jones L; Al-Shehhi H; Erhorn A; Russell LJ; Moorman AV; Harrison CJ
Haematologica; 2013 Jul; 98(7):1081-8. PubMed ID: 23508010
[TBL] [Abstract][Full Text] [Related]
8. Impact of IKZF1 deletions and PAX5 amplifications in pediatric B-cell precursor ALL treated according to NOPHO protocols.
Ofverholm I; Tran AN; Heyman M; Zachariadis V; Nordenskjöld M; Nordgren A; Barbany G
Leukemia; 2013 Sep; 27(9):1936-9. PubMed ID: 23538749
[No Abstract] [Full Text] [Related]
9. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
[TBL] [Abstract][Full Text] [Related]
10.
Lopes BA; Barbosa TC; Souza BKS; Poubel CP; Pombo-de-Oliveira MS; Emerenciano M;
Cancer Prev Res (Phila); 2017 Dec; 10(12):738-744. PubMed ID: 28947432
[TBL] [Abstract][Full Text] [Related]
11. High frequency of intermediate and poor risk copy number abnormalities in pediatric cohort of B-ALL correlate with high MRD post induction.
Singh M; Bhatia P; Trehan A; Varma N; Sachdeva MS; Bansal D; Jain R; Naseem S
Leuk Res; 2018 Mar; 66():79-84. PubMed ID: 29407587
[TBL] [Abstract][Full Text] [Related]
12. Digital Multiplex Ligation-Dependent Probe Amplification for Detection of Key Copy Number Alterations in T- and B-Cell Lymphoblastic Leukemia.
Benard-Slagter A; Zondervan I; de Groot K; Ghazavi F; Sarhadi V; Van Vlierberghe P; De Moerloose B; Schwab C; Vettenranta K; Harrison CJ; Knuutila S; Schouten J; Lammens T; Savola S
J Mol Diagn; 2017 Sep; 19(5):659-672. PubMed ID: 28736295
[TBL] [Abstract][Full Text] [Related]
13. Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic Leukemia with Prognosis.
Hosein Pour Feizi A; Zeinali S; Toporski J; Sheervalilou R; Mehranfar S
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3493-3500. PubMed ID: 33369444
[TBL] [Abstract][Full Text] [Related]
14. Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia.
Steeghs EMP; Boer JM; Hoogkamer AQ; Boeree A; de Haas V; de Groot-Kruseman HA; Horstmann MA; Escherich G; Pieters R; den Boer ML
Sci Rep; 2019 Mar; 9(1):4634. PubMed ID: 30874617
[TBL] [Abstract][Full Text] [Related]
15. IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.
Kuiper RP; Waanders E; van der Velden VH; van Reijmersdal SV; Venkatachalam R; Scheijen B; Sonneveld E; van Dongen JJ; Veerman AJ; van Leeuwen FN; van Kessel AG; Hoogerbrugge PM
Leukemia; 2010 Jul; 24(7):1258-64. PubMed ID: 20445578
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling of gene copy number abnormalities in key regulatory genes in high-risk B-lineage acute lymphoblastic leukemia: frequency and their association with clinicopathological findings in Indian patients.
Bhandari P; Ahmad F; Das BR
Med Oncol; 2017 May; 34(5):92. PubMed ID: 28401483
[TBL] [Abstract][Full Text] [Related]
17. High expression of miR-125b-2 and SNORD116 noncoding RNA clusters characterize ERG-related B cell precursor acute lymphoblastic leukemia.
Vendramini E; Giordan M; Giarin E; Michielotto B; Fazio G; Cazzaniga G; Biondi A; Silvestri D; Valsecchi MG; Muckenthaler MU; Kulozik AE; Gattei V; Izraeli S; Basso G; Te Kronnie G
Oncotarget; 2017 Jun; 8(26):42398-42413. PubMed ID: 28415578
[TBL] [Abstract][Full Text] [Related]
18. SH2B3 aberrations enriched in iAMP21 B lymphoblastic leukemia.
Baughn LB; Meredith MM; Oseth L; Smolarek TA; Hirsch B
Cancer Genet; 2018 Oct; 226-227():30-35. PubMed ID: 30005852
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of multiplex ligation-dependent probe amplification as a method for the detection of copy number abnormalities in B-cell precursor acute lymphoblastic leukemia.
Schwab CJ; Jones LR; Morrison H; Ryan SL; Yigittop H; Schouten JP; Harrison CJ
Genes Chromosomes Cancer; 2010 Dec; 49(12):1104-13. PubMed ID: 20815030
[TBL] [Abstract][Full Text] [Related]
20. Integration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: a multi-institution, multi-platform microarray study.
Baughn LB; Biegel JA; South ST; Smolarek TA; Volkert S; Carroll AJ; Heerema NA; Rabin KR; Zweidler-McKay PA; Loh M; Hirsch B
Cancer Genet; 2015; 208(1-2):1-18. PubMed ID: 25678190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
